Clinical Trials Logo

Filter by:
NCT ID: NCT04215302 Completed - General Anaesthesia Clinical Trials

Prediction Accuracy for Langeal Mask Unique TM Size in Pediatric Patient

Start date: September 17, 2019
Phase:
Study type: Observational

the study aimed to know the accuracy for laryngeal mask unique TM size to Malay pediatric race according to weight measurement recommended by manufacturer

NCT ID: NCT04215289 Completed - Clinical trials for Qnox Values as a Predictor of Pain Response

Compatibility of Qnox Values With Hemodynamic Changes in Tracheal Intubation Procedures

Start date: November 26, 2019
Phase:
Study type: Observational

The study aimed to analyze the compatibility of Qnox values with hemodynamic changes as a predictor of pain response in tracheal intubation procedures

NCT ID: NCT04215276 Completed - Brachytherapy Clinical Trials

Valsalva Maneuver and Control in Reducing Pain During Spinal Injection

Start date: January 21, 2019
Phase: N/A
Study type: Interventional

The study aimed to compare the effectiveness of Valsalva maneuver as non pharmacological approach and control in reducing pain during spinal injection.

NCT ID: NCT04215263 Completed - Clinical trials for Undergoing General Anaesthesia

Risk Factors of POCD in General Anesthesia Patients Underwent Noncardiac and Non Neurological Procedures.

Start date: May 1, 2019
Phase:
Study type: Observational

The study was a prospective cohort study to assess the effect of age, duration of anesthesia, repeated surgery, and type of surgery on cognitive impairment in 108 geriatric patients (≥60 years) who underwent general anesthesia for non-neurologic noncardiac surgery.

NCT ID: NCT04215250 Completed - Clinical trials for Depth of CVC Insertion

Accuracy of CVC Depth Prediction in Internal Jugular Veins: The Difference Between The Andropoulos and ECG Methods

Start date: December 12, 2019
Phase: N/A
Study type: Interventional

compare the accuracy of CVC depth prediction in internal jugular veins: the difference between the andropoulos and ECG methods

NCT ID: NCT04208789 Completed - Clinical trials for Resistance to Tuberculostatic Drugs

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Start date: June 15, 2020
Phase:
Study type: Observational

Title: Artificial Neural Network as Diagnostic Tools For Rifampicin-Resistant Tuberculosis In Indonesia. A Predictive Model Study and Economic Evaluation. Background: Drug-resistant tuberculosis has become a global threat particularly in Indonesia. The need to increase detection, followed by appropriate treatment is a concern in dealing with these cases. The rapid molecular test (specifically for detecting rifampicin-resistant) is now being utilized in health care service, particularly at primary care level with some challenges including the lack of quality control (including how to obtained and treat the specimen properly prior to the examination) which then, affect the reliability of the results. Drug-Susceptibility Test (DST) is still, the gold standard in diagnosing drug-resistant tuberculosis but this procedure is time-consuming and costly. The artificial intelligent including data exploration and modeling is a promising method to classify potential drug-resistant cases based on the association of several factors. Objective : 1. To develop a model using an artificial intelligence approach that is able to classify the possibility of rifampicin-resistant tuberculosis. 2. To assess the diagnostic ability and the accuracy of the model in comparison to existing rapid test and the gold standard 3. To evaluate the cost-effectiveness evaluation of Artificial Neural Network model in Web-Based Application in comparison with the standard diagnostic tools Methodology 1. A cross-sectional study involving all suspected drug-resistant tuberculosis cases that being referred to the study center to undergo rapid molecular test and DST test over the past 5 years. 2. A comprehensive, retrospective medical records assessment and tuberculosis individual report will be performed to obtain a variable of interest. 3. Questionnaire assessment for confirmation of insufficient information. 4. Model Building through machine learning and deep learning procedure 5. Model Validation and testing using training data set and data from the different study center Hypothesis : Artificial Intelligent Model will yield a similar or superior result of diagnostic ability compare the Rapid Molecular Test according to the Drug-Susceptibility Test. (Superiority Trial)

NCT ID: NCT04206579 Completed - Athletes Clinical Trials

Oral Dextrose Formula in Performance of Soccer Athlete

Start date: March 25, 2019
Phase: N/A
Study type: Interventional

I. Title of Proposed Research Project Dextrose 10% Drink Increase Blood Sugar and Sprint Velocity Compared to Sodium Dextrose in Soccer Players II. Specific Aims This study aims to evaluate the ergogenic effect in terms of blood sugar, VO2 max and sprint speed of dextrose 10% compared with sodium dextrose 10% in young male soccer players. III. Background Sports drinks are designed to provide CHO, electrolytes, and fluids to the body, which are absorbed very fast from the small intestine. In other words, the period from ingestion until the CHO, electrolytes, and fluids reach the muscles, brain and so on, should be very short. This is the most important advantage of using sports drinks (Simulescu, Ilia, Macarie, & Merghes, 2019). Commercial sports drinks generally contain both of CHO and sodium; To the best of the investigator's knowledge, there is no trial in which compare the differential effect of solely dextrose supplementation versus sodium dextrose in soccer players in terms of BG concentration, VO2 max and sprint speed, which may give a new paradigm for the available ergogenic sports drink.

NCT ID: NCT04188223 Completed - Hepatitis B Clinical Trials

Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children

Start date: December 3, 2019
Phase: Phase 1
Study type: Interventional

This trial is an experimental, randomized, double blind, prospective intervention study Approximately 100 subjects will be enrolled in this trial, divided into 2 arms, as follow: For adult (18-40 years old)

NCT ID: NCT04187755 Completed - Leukemia Clinical Trials

Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever

Start date: March 1, 2019
Phase: Phase 4
Study type: Interventional

Empirical antibiotic therapy has been known to reduce the mortality and morbidity rate in neutropenic fever. Until now, ceftazidime was the first line choice of neutropenic fever. However, resistance against ceftazidime has been reported. Several countries have reported cefepime in reducing fever and shorten the length of hospitalization better than ceftazidime. This study is aimed to compare the effectivity of ceftazidime and cefepime to reduce fever and to increase the absolute neutrophils count (ANC) in the first 72 hours.

NCT ID: NCT04187313 Completed - Tuberculosis Clinical Trials

Increasing Notifications of Tuberculosis From Private Practitioners

INSTEP2
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

Tuberculosis (TB) is the third leading cause of death in Indonesia. Disturbingly, the prevalence survey showed that over half of TB cases in Indonesia are not notified. The huge private sector in Indonesia, comprising an estimated 70,000 practitioners, provides over 50% of health care but notifies less than 10% of all diagnosed TB cases. INSTEP2 is a cluster randomised controlled intervention trial. The multi-component public health intervention will be administered to private practitioners (PP) in Community Health Centre (CHC) clusters. The change in the number of TB notifications over 12 months before, and 12 months after, the intervention will be compared between study arms. Hypothesis related to the Primary Efficacy Endpoint: A tailored intervention in PPs will increase TB notifications.